USANA Health ( (USNA) ) just unveiled an update.
USANA Health Sciences reported its financial results for the first quarter of 2025, showing a 10% increase in net sales compared to the same period in 2024, despite a decline in net earnings and diluted EPS. The company reiterated its full-year outlook, highlighting strong growth in its Hiya direct-to-consumer business and a modest increase in direct sales and active customers. USANA is confident in its growth trajectory, despite global economic uncertainties, and continues to manage its supply chain effectively to mitigate potential impacts from trade policies and tariffs.
Spark’s Take on USNA Stock
According to Spark, TipRanks’ AI Analyst, USNA is a Neutral.
USANA Health’s overall stock score reflects strong financial stability with a solid balance sheet and low leverage. However, declining revenues and net profit margins, coupled with downward technical indicators, pose challenges. The strategic acquisition and positive guidance from the earnings call moderately offset these concerns, contributing to an overall stable outlook.
To see Spark’s full report on USNA stock, click here.
More about USANA Health
USANA Health Sciences is a company operating in the health and wellness industry, primarily offering nutritional and personal care products. The company focuses on direct selling and has recently expanded into direct-to-consumer channels through its acquisition of Hiya.
YTD Price Performance: -34.51%
Average Trading Volume: 215,448
Technical Sentiment Signal: Buy
Current Market Cap: $449.4M
For a thorough assessment of USNA stock, go to TipRanks’ Stock Analysis page.